Rankings
▼
Calendar
TRDA FY 2025 Earnings — Entrada Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
TRDA
Entrada Therapeutics, Inc.
$502M
FY 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$25M
-87.9% YoY
Gross Profit
$21M
83.9% margin
Operating Income
-$156M
-613.7% margin
Net Income
-$144M
-565.5% margin
EPS (Diluted)
$-3.47
Cash Flow
Operating Cash Flow
-$129M
Free Cash Flow
-$130M
Stock-Based Comp.
$20M
Balance Sheet
Total Assets
$377M
Total Liabilities
$71M
Stockholders' Equity
$306M
Cash & Equivalents
$90M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$25M
$211M
-87.9%
Gross Profit
$21M
$211M
-89.9%
Operating Income
-$156M
$47M
-431.8%
Net Income
-$144M
$66M
-319.0%
← Q4 2024
All Quarters
Q1 2025 →